878 related articles for article (PubMed ID: 27631313)
1. Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision of mid-low rectal cancer following neoadjuvant chemoradiation therapy.
Lim DR; Bae SU; Hur H; Min BS; Baik SH; Lee KY; Kim NK
Surg Endosc; 2017 Apr; 31(4):1728-1737. PubMed ID: 27631313
[TBL] [Abstract][Full Text] [Related]
2. Robotic Resection is a Good Prognostic Factor in Rectal Cancer Compared with Laparoscopic Resection: Long-term Survival Analysis Using Propensity Score Matching.
Kim J; Baek SJ; Kang DW; Roh YE; Lee JW; Kwak HD; Kwak JM; Kim SH
Dis Colon Rectum; 2017 Mar; 60(3):266-273. PubMed ID: 28177988
[TBL] [Abstract][Full Text] [Related]
3. Total mesorectal excision for mid and low rectal cancer: Laparoscopic vs robotic surgery.
Feroci F; Vannucchi A; Bianchi PP; Cantafio S; Garzi A; Formisano G; Scatizzi M
World J Gastroenterol; 2016 Apr; 22(13):3602-10. PubMed ID: 27053852
[TBL] [Abstract][Full Text] [Related]
4. Comparison of short-term and oncologic outcomes of robotic and laparoscopic resection for mid- and distal rectal cancer.
Law WL; Foo DCC
Surg Endosc; 2017 Jul; 31(7):2798-2807. PubMed ID: 27785627
[TBL] [Abstract][Full Text] [Related]
5. Robotic versus laparoscopic sphincter-saving total mesorectal excision for mid or low rectal cancer in male patients after neoadjuvant chemoradiation therapy: comparison of long-term outcomes.
Asoglu O; Tokmak H; Bakir B; Aliyev V; Saglam S; Iscan Y; Bademler S; Meric S
J Robot Surg; 2020 Jun; 14(3):393-399. PubMed ID: 31313071
[TBL] [Abstract][Full Text] [Related]
6. Completely Abdominal Approach Laparoscopic Partial Intersphincteric Resection After Neoadjuvant Chemoradiation for Initial cT3 Juxta-Anal Rectal Cancer.
Huang S; Huang Y; Chi P; Lin H; Lu X; Xu Z; Sun Y; Wang X
J Laparoendosc Adv Surg Tech A; 2019 Jun; 29(6):809-816. PubMed ID: 30596539
[No Abstract] [Full Text] [Related]
7. Robotic versus open total mesorectal excision for rectal cancer: comparative study of short and long-term outcomes.
Ghezzi TL; Luca F; Valvo M; Corleta OC; Zuccaro M; Cenciarelli S; Biffi R
Eur J Surg Oncol; 2014 Sep; 40(9):1072-9. PubMed ID: 24646748
[TBL] [Abstract][Full Text] [Related]
8. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
[TBL] [Abstract][Full Text] [Related]
9. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
[TBL] [Abstract][Full Text] [Related]
11. Long-term oncological outcomes in robotic versus laparoscopic approach for rectal cancer: A systematic review and meta-analysis.
Qiu H; Yu D; Ye S; Shan R; Ai J; Shi J
Int J Surg; 2020 Aug; 80():225-230. PubMed ID: 32251720
[TBL] [Abstract][Full Text] [Related]
12. The long-term oncological outcomes of the 140 robotic sphincter-saving total mesorectal excision for rectal cancer: a single surgeon experience.
Aliyev V; Tokmak H; Goksel S; Meric S; Acar S; Kaya H; Asoglu O
J Robot Surg; 2020 Aug; 14(4):655-661. PubMed ID: 31811567
[TBL] [Abstract][Full Text] [Related]
13. Robotic versus laparoscopic surgery for mid-low rectal cancer after neoadjuvant chemoradiation therapy: comparison of oncologic outcomes.
Saklani AP; Lim DR; Hur H; Min BS; Baik SH; Lee KY; Kim NK
Int J Colorectal Dis; 2013 Dec; 28(12):1689-98. PubMed ID: 23948968
[TBL] [Abstract][Full Text] [Related]
14. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial.
Park JW; Kang SB; Hao J; Lim SB; Choi HS; Kim DW; Chang HJ; Kim DY; Jung KH; Kim TY; Kang GH; Chie EK; Kim SY; Sohn DK; Kim JS; Lee HS; Kim JH; Jeong SY; Oh JH
Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):569-577. PubMed ID: 33894918
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer.
Marks JH; Myers EA; Zeger EL; Denittis AS; Gummadi M; Marks GJ
Surg Endosc; 2017 Dec; 31(12):5248-5257. PubMed ID: 28643051
[TBL] [Abstract][Full Text] [Related]
16. Oncologic and Clinicopathologic Outcomes of Robot-Assisted Total Mesorectal Excision for Rectal Cancer.
Pai A; Marecik SJ; Park JJ; Melich G; Sulo S; Prasad LM
Dis Colon Rectum; 2015 Jul; 58(7):659-67. PubMed ID: 26200680
[TBL] [Abstract][Full Text] [Related]
17. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial.
Kang SB; Park JW; Jeong SY; Nam BH; Choi HS; Kim DW; Lim SB; Lee TG; Kim DY; Kim JS; Chang HJ; Lee HS; Kim SY; Jung KH; Hong YS; Kim JH; Sohn DK; Kim DH; Oh JH
Lancet Oncol; 2010 Jul; 11(7):637-45. PubMed ID: 20610322
[TBL] [Abstract][Full Text] [Related]
18. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
[TBL] [Abstract][Full Text] [Related]
19. Robotic coloanal anastomosis with or without intersphincteric resection for low rectal cancer: starting with the perianal approach followed by robotic procedure.
Kang J; Hur H; Min BS; Lee KY; Kim NK
Ann Surg Oncol; 2012 Jan; 19(1):154-5. PubMed ID: 21822556
[TBL] [Abstract][Full Text] [Related]
20. Sphincter-Saving Robotic Total Mesorectal Excision Provides Better Mesorectal Specimen and Good Oncological Local Control Compared with Laparoscopic Total Mesorectal Excision in Male Patients with Mid-Low Rectal Cancer.
Aliyev V; Goksel S; Bakir B; Guven K; Asoglu O
Surg Technol Int; 2021 May; 38():160-166. PubMed ID: 33537982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
